Impact of Chronic Tetracycline Exposure on Human Intestinal Microbiota in a Continuous Flow Bioreactor Model

Studying potential dietary exposure to antimicrobial drug residues via meat and dairy products is essential to ensure human health and consumer safety. When studying how antimicrobial residues in food impact the development of antimicrobial drug resistance and disrupt normal bacteria community struc...

Full description

Bibliographic Details
Main Authors: Youngbeom Ahn, Ji Young Jung, Ohgew Kweon, Brian T. Veach, Sangeeta Khare, Kuppan Gokulan, Silvia A. Piñeiro, Carl E. Cerniglia
Format: Article
Language:English
Published: MDPI AG 2021-07-01
Series:Antibiotics
Subjects:
Online Access:https://www.mdpi.com/2079-6382/10/8/886
_version_ 1797524903651442688
author Youngbeom Ahn
Ji Young Jung
Ohgew Kweon
Brian T. Veach
Sangeeta Khare
Kuppan Gokulan
Silvia A. Piñeiro
Carl E. Cerniglia
author_facet Youngbeom Ahn
Ji Young Jung
Ohgew Kweon
Brian T. Veach
Sangeeta Khare
Kuppan Gokulan
Silvia A. Piñeiro
Carl E. Cerniglia
author_sort Youngbeom Ahn
collection DOAJ
description Studying potential dietary exposure to antimicrobial drug residues via meat and dairy products is essential to ensure human health and consumer safety. When studying how antimicrobial residues in food impact the development of antimicrobial drug resistance and disrupt normal bacteria community structure in the intestine, there are diverse methodological challenges to overcome. In this study, traditional cultures and molecular analysis techniques were used to determine the effects of tetracycline at chronic subinhibitory exposure levels on human intestinal microbiota using an in vitro continuous flow bioreactor. Six bioreactor culture vessels containing human fecal suspensions were maintained at 37 °C for 7 days. After a steady state was achieved, the suspensions were dosed with 0, 0.015, 0.15, 1.5, 15, or 150 µg/mL tetracycline, respectively. Exposure to 150 µg/mL tetracycline resulted in a decrease of total anaerobic bacteria from 1.9 × 10<sup>7</sup> ± 0.3 × 10<sup>7</sup> down to 2 × 10<sup>6</sup> ± 0.8 × 10<sup>6</sup> CFU/mL. Dose-dependent effects of tetracycline were noted for perturbations of <i>tetB</i> and <i>tetD</i> gene expression and changes in acetate and propionate concentrations. Although no-observed-adverse-effect concentrations differed, depending on the traditional cultures and the molecular analysis techniques used, this in vitro continuous flow bioreactor study contributes to the knowledge base regarding the impact of chronic exposure of tetracycline on human intestinal microbiota.
first_indexed 2024-03-10T09:04:15Z
format Article
id doaj.art-5310526589fa4200887199dd5d565ad8
institution Directory Open Access Journal
issn 2079-6382
language English
last_indexed 2024-03-10T09:04:15Z
publishDate 2021-07-01
publisher MDPI AG
record_format Article
series Antibiotics
spelling doaj.art-5310526589fa4200887199dd5d565ad82023-11-22T06:32:46ZengMDPI AGAntibiotics2079-63822021-07-0110888610.3390/antibiotics10080886Impact of Chronic Tetracycline Exposure on Human Intestinal Microbiota in a Continuous Flow Bioreactor ModelYoungbeom Ahn0Ji Young Jung1Ohgew Kweon2Brian T. Veach3Sangeeta Khare4Kuppan Gokulan5Silvia A. Piñeiro6Carl E. Cerniglia7Division of Microbiology, National Center for Toxicological Research, U.S. Food and Drug Administration, Jefferson, AR 72079, USADivision of Microbiology, National Center for Toxicological Research, U.S. Food and Drug Administration, Jefferson, AR 72079, USADivision of Microbiology, National Center for Toxicological Research, U.S. Food and Drug Administration, Jefferson, AR 72079, USAOffice of Regulatory Affairs, Arkansas Laboratory, U.S. Food and Drug Administration, Jefferson, AR 72079, USADivision of Microbiology, National Center for Toxicological Research, U.S. Food and Drug Administration, Jefferson, AR 72079, USADivision of Microbiology, National Center for Toxicological Research, U.S. Food and Drug Administration, Jefferson, AR 72079, USADivision of Human Food Safety, Center for Veterinary Medicine, U.S. Food and Drug Administration, Rockville, MD 72079, USADivision of Microbiology, National Center for Toxicological Research, U.S. Food and Drug Administration, Jefferson, AR 72079, USAStudying potential dietary exposure to antimicrobial drug residues via meat and dairy products is essential to ensure human health and consumer safety. When studying how antimicrobial residues in food impact the development of antimicrobial drug resistance and disrupt normal bacteria community structure in the intestine, there are diverse methodological challenges to overcome. In this study, traditional cultures and molecular analysis techniques were used to determine the effects of tetracycline at chronic subinhibitory exposure levels on human intestinal microbiota using an in vitro continuous flow bioreactor. Six bioreactor culture vessels containing human fecal suspensions were maintained at 37 °C for 7 days. After a steady state was achieved, the suspensions were dosed with 0, 0.015, 0.15, 1.5, 15, or 150 µg/mL tetracycline, respectively. Exposure to 150 µg/mL tetracycline resulted in a decrease of total anaerobic bacteria from 1.9 × 10<sup>7</sup> ± 0.3 × 10<sup>7</sup> down to 2 × 10<sup>6</sup> ± 0.8 × 10<sup>6</sup> CFU/mL. Dose-dependent effects of tetracycline were noted for perturbations of <i>tetB</i> and <i>tetD</i> gene expression and changes in acetate and propionate concentrations. Although no-observed-adverse-effect concentrations differed, depending on the traditional cultures and the molecular analysis techniques used, this in vitro continuous flow bioreactor study contributes to the knowledge base regarding the impact of chronic exposure of tetracycline on human intestinal microbiota.https://www.mdpi.com/2079-6382/10/8/886tetracyclinechronic exposurehuman intestinal microbiotacontinuous flow bioreactor model
spellingShingle Youngbeom Ahn
Ji Young Jung
Ohgew Kweon
Brian T. Veach
Sangeeta Khare
Kuppan Gokulan
Silvia A. Piñeiro
Carl E. Cerniglia
Impact of Chronic Tetracycline Exposure on Human Intestinal Microbiota in a Continuous Flow Bioreactor Model
Antibiotics
tetracycline
chronic exposure
human intestinal microbiota
continuous flow bioreactor model
title Impact of Chronic Tetracycline Exposure on Human Intestinal Microbiota in a Continuous Flow Bioreactor Model
title_full Impact of Chronic Tetracycline Exposure on Human Intestinal Microbiota in a Continuous Flow Bioreactor Model
title_fullStr Impact of Chronic Tetracycline Exposure on Human Intestinal Microbiota in a Continuous Flow Bioreactor Model
title_full_unstemmed Impact of Chronic Tetracycline Exposure on Human Intestinal Microbiota in a Continuous Flow Bioreactor Model
title_short Impact of Chronic Tetracycline Exposure on Human Intestinal Microbiota in a Continuous Flow Bioreactor Model
title_sort impact of chronic tetracycline exposure on human intestinal microbiota in a continuous flow bioreactor model
topic tetracycline
chronic exposure
human intestinal microbiota
continuous flow bioreactor model
url https://www.mdpi.com/2079-6382/10/8/886
work_keys_str_mv AT youngbeomahn impactofchronictetracyclineexposureonhumanintestinalmicrobiotainacontinuousflowbioreactormodel
AT jiyoungjung impactofchronictetracyclineexposureonhumanintestinalmicrobiotainacontinuousflowbioreactormodel
AT ohgewkweon impactofchronictetracyclineexposureonhumanintestinalmicrobiotainacontinuousflowbioreactormodel
AT briantveach impactofchronictetracyclineexposureonhumanintestinalmicrobiotainacontinuousflowbioreactormodel
AT sangeetakhare impactofchronictetracyclineexposureonhumanintestinalmicrobiotainacontinuousflowbioreactormodel
AT kuppangokulan impactofchronictetracyclineexposureonhumanintestinalmicrobiotainacontinuousflowbioreactormodel
AT silviaapineiro impactofchronictetracyclineexposureonhumanintestinalmicrobiotainacontinuousflowbioreactormodel
AT carlecerniglia impactofchronictetracyclineexposureonhumanintestinalmicrobiotainacontinuousflowbioreactormodel